Literature DB >> 22127381

[Current S3 guidelines on surgical treatment of gastric carcinoma].

H-J Meyer1, A H Hölscher, F Lordick, H Messmann, S Mönig, C Schumacher, M Stahl, H Wilke, M Möhler.   

Abstract

The current S3 guidelines on the diagnosis and treatment of gastric carcinoma including those of the esophagogastric junction describe optimal clinical practice based on a high level of evidence and expert consensus from different medical disciplines. Endoscopy and performance of multiple biopsies is the standard approach to detect malignant tumors in the upper gastrointestinal tract. Further diagnostic procedures are necessary to evaluate the tumor stage. With the exception of mucosal carcinomas, surgical therapy is the cornerstone of curative treatment in all potentially resectable stages. In locally advanced carcinomas perioperative chemotherapy should be carried out and in high-seated tumors preoperative radiochemotherapy might be an alternative option. Palliative surgical resection should be avoided in disseminated asymptomatic stages. In a palliative situation complications of the tumor should primarily be treated by interventional or conservative procedures.

Entities:  

Mesh:

Year:  2012        PMID: 22127381     DOI: 10.1007/s00104-011-2149-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  27 in total

1.  Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy.

Authors:  Markku E Voutilainen; Matti T Juhola
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-12       Impact factor: 2.566

2.  [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Authors:  M Moehler; S-E Al-Batran; T Andus; M Anthuber; J Arends; D Arnold; D Aust; P Baier; G Baretton; J Bernhardt; H Boeing; E Böhle; C Bokemeyer; J Bornschein; W Budach; E Burmester; K Caca; W A Diemer; C F Dietrich; M Ebert; A Eickhoff; C Ell; J Fahlke; H Feussner; R Fietkau; W Fischbach; W Fleig; M Flentje; H E Gabbert; P R Galle; M Geissler; I Gockel; U Graeven; L Grenacher; S Gross; J T Hartmann; M Heike; V Heinemann; B Herbst; T Herrmann; S Höcht; R D Hofheinz; H Höfler; T Höhler; A H Hölscher; M Horneber; J Hübner; J R Izbicki; R Jakobs; C Jenssen; S Kanzler; M Keller; R Kiesslich; G Klautke; J Körber; B J Krause; C Kuhn; F Kullmann; H Lang; H Link; F Lordick; K Ludwig; M Lutz; R Mahlberg; P Malfertheiner; S Merkel; H Messmann; H-J Meyer; S Mönig; P Piso; S Pistorius; R Porschen; T Rabenstein; P Reichardt; K Ridwelski; C Röcken; I Roetzer; P Rohr; W Schepp; P M Schlag; R M Schmid; H Schmidberger; W-H Schmiegel; H-J Schmoll; G Schuch; C Schuhmacher; K Schütte; W Schwenk; M Selgrad; A Sendler; J Seraphin; T Seufferlein; M Stahl; H Stein; C Stoll; M Stuschke; A Tannapfel; R Tholen; P Thuss-Patience; K Treml; U Vanhoefer; M Vieth; H Vogelsang; D Wagner; U Wedding; A Weimann; H Wilke; C Wittekind
Journal:  Z Gastroenterol       Date:  2011-04-07       Impact factor: 2.000

Review 3.  pTNM and residual tumor classifications: problems of assessment and prognostic significance.

Authors:  P Hermanek
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

5.  Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?

Authors:  Suhsien Lim; Bart E Muhs; Stuart G Marcus; Elliot Newman; Russel S Berman; Spiros P Hiotis
Journal:  J Surg Oncol       Date:  2007-02-01       Impact factor: 3.454

6.  Attempted salvage resection for recurrent gastric or gastroesophageal cancer.

Authors:  Brian Badgwell; Janice N Cormier; Yan Xing; James Yao; Debashish Bose; Sunil Krishnan; Peter Pisters; Barry Feig; Paul Mansfield
Journal:  Ann Surg Oncol       Date:  2008-11-05       Impact factor: 5.344

7.  Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.

Authors:  Ken Shirabe; Mitsuo Shimada; Takashi Matsumata; Hidefumi Higashi; Yohichi Yakeishi; Shigeki Wakiyama; Yasuharu Ikeda; Takuhiro Ezaki; Shingo Fukuzawa; Kenji Takenaka; Keishi Kishikawa; Tetsuo Ikeda; Ken-ichi Taguchi; Yoshihiko Maehara; Keizo Sugimachi
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

Review 8.  [Diagnosis of and therapy for gastric cancer--work-flow].

Authors:  R T Grundmann; A H Hölscher; A Bembenek; E Bollschweiler; O Drognitz; S Feuerbach; I Gastinger; P Hermanek; U T Hopt; M Hünerbein; G Illerhaus; T Junginger; M Kraus; A Meining; S Merkel; H J Meyer; S P Mönig; P Piso; J Roder; C Rödel; A Tannapfel; C Wittekind; G Woeste
Journal:  Zentralbl Chir       Date:  2009-08-17       Impact factor: 0.942

9.  Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study.

Authors:  H Isomoto; S Shikuwa; N Yamaguchi; E Fukuda; K Ikeda; H Nishiyama; K Ohnita; Y Mizuta; J Shiozawa; S Kohno
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  21 in total

Review 1.  Gastric cancer treatment in the world: Germany.

Authors:  Seung-Hun Chon; Felix Berlth; Patrick Sven Plum; Till Herbold; Hakan Alakus; Robert Kleinert; Stefan Paul Moenig; Christiane Josephine Bruns; Arnulf Heinrich Hoelscher; Hans-Joachim Meyer
Journal:  Transl Gastroenterol Hepatol       Date:  2017-05-26

Review 2.  Preoperative staging of nodal status in gastric cancer.

Authors:  Felix Berlth; Seung-Hun Chon; Mickael Chevallay; Minoa Karin Jung; Stefan Paul Mönig
Journal:  Transl Gastroenterol Hepatol       Date:  2017-02-07

Review 3.  Lymphadenectomy: how to do it?

Authors:  Simone Giacopuzzi; Maria Bencivenga; Chiara Cipollari; Jacopo Weindelmayer; Giovanni de Manzoni
Journal:  Transl Gastroenterol Hepatol       Date:  2017-04-07

Review 4.  Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives.

Authors:  Valentina Mengardo; Maria Bencivenga; Jacopo Weindelmayer; Michele Pavarana; Simone Giacopuzzi; Giovanni de Manzoni
Journal:  Updates Surg       Date:  2018-05-30

Review 5.  [Frozen sections diagnostics in visceral surgery. Stomach and intestines].

Authors:  B Oberschmid; A Dietrich; C Wittekind
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

6.  [New S3 guideline for esophageal cancer : Important surgical aspects].

Authors:  A H Hölscher; M Stahl; H Messmann; M Stuschke; H J Meyer; R Porschen
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

7.  [Minimally invasive oncological surgery of the upper gastrointestinal tract : state of the art].

Authors:  C J Bruns
Journal:  Chirurg       Date:  2014-08       Impact factor: 0.955

Review 8.  [Surgical treatment of gastric carcinoma. German multicenter observational studies].

Authors:  K Ridwelski; I Gastinger; H Ptok; F Meyer; H Dralle; H Lippert
Journal:  Chirurg       Date:  2013-01       Impact factor: 0.955

Review 9.  Gastric cancer: Current status of lymph node dissection.

Authors:  Maurizio Degiuli; Giovanni De Manzoni; Alberto Di Leo; Domenico D'Ugo; Erica Galasso; Daniele Marrelli; Roberto Petrioli; Karol Polom; Franco Roviello; Francesco Santullo; Mario Morino
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 10.  [Treatment of gastric cancer beyond current guideline: state of the art].

Authors:  C Schuhmacher; A Novotny; H-J Meyer
Journal:  Chirurg       Date:  2013-04       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.